News and Announcements
Alcidion Group (ASX:ALC) Releases an Advanced Suite of Electronic Referrals Software, Miya iScheduler
- Published July 10, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Alcidion Group Limited (ASX:ALC) announces the release of an advanced suite of electronic referrals software within its Miya family of advanced health informatics products for faster and improved healthcare.
KEY TAKEAWAYS:
- Miya iScheduler, the software is able to significantly improve the access of patients to hospital outpatient services, delivered to remote locations and the home.
- The software is of high value to GP’s, allied health professionals, community nurses and other care providers who are interacting with hospitals and other services to arrange timely care and support for their patients.
Ray Blight said: “we believe the breadth of functionality available within Miya iScheduler will be of appeal to large scale, multi-function, multi-service implementations – large in the sense of high numbers of patients in dense urban area, but also for small populations spread over large geographical areas, where the telehealth capability comes into play”.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
